ANS Introduces Industry's First Curved Leads Designed to Focus Stimulation for Pain Relief
01 September 2004 - 11:02PM
PR Newswire (US)
ANS Introduces Industry's First Curved Leads Designed to Focus
Stimulation for Pain Relief New Leads Facilitate Precise Lead
Placement and More Efficient Use of ANS' Neurostimulation Systems
PLANO, Texas, Sept. 1 /PRNewswire-FirstCall/ -- Advanced
Neuromodulation Systems, Inc. (NASDAQ:ANSI) (ANS) today introduced
its line of C-Series Lamitrode(R) leads, the market's first set of
leads to mimic the curve of the epidural space -- the space between
the spine and the spinal cord. These curved leads are designed to
direct stimulation toward the spinal cord and to minimize unwanted
stimulation in the posterior epidural space. Moreover, the C-Series
Lamitrode leads facilitate lead insertion and placement. (Photo:
http://www.newscom.com/cgi-bin/prnh/20040901/DAW008 ) "There is an
observable and dramatic positive difference when placing ANS'
C-Series leads during spinal cord stimulation cases," said Dr. F.
Richard Jordan. "The curved design makes placement easier,
decreases the chance for lead movement and helps to reduce overall
operation time." The C-Series leads feature two rows of electrodes
with wide lateral spacing to enhance bilateral stimulation. The
electrodes are shielded to focus the electrical current in one
direction. This unidirectional current makes it possible to provide
therapy at lower power levels, resulting in greater system
efficiency and longer battery life. "ANS' engineering team designed
the C-Series Lamitrode leads to benefit the physician and patient,"
said ANS President and CEO Chris Chavez. "With this new product, we
continue to demonstrate technology leadership in the rapidly
growing neuromodulation market." The C-Series Lamitrode leads
extend ANS' already broad line of neurostimulation leads. The
breadth of this line allows physicians to select the lead that best
fits each patient's unique anatomical needs. With the choices of
percutaneous, surgical, and trial leads, physicians can facilitate
precise stimulation and satisfy placement preferences without
compromising performance. About chronic pain Chronic pain affects
an estimated 50 million Americans, of whom more than half are
partially or totally disabled. At present, approximately $100
billion are spent in the U.S. on the diagnosis and treatment of
chronic pain, which represents the most common indication for
spinal cord stimulation therapy. The 106th U.S. Congress has
declared this the "Decade of Pain Control and Research," helping to
bring spinal cord stimulation to the forefront as a viable and
effective option in the treatment of chronic pain. About Advanced
Neuromodulation Systems (ANS) Advanced Neuromodulation Systems,
Inc. designs, develops, manufactures and markets implantable
systems used to manage chronic intractable pain and other disorders
of the central nervous system. A technology leader in the
neuromodulation industry, ANS offers a family of proprietary
neurostimulation devices and implantable drug pumps for an
expanding range of therapeutic applications. ANS was recently named
among FORTUNE's 100 Fastest Growing Companies and has been
recognized among Forbes' 200 Best Small Companies for two
consecutive years. Frost & Sullivan also honored the company
with its Product Innovation Award. ANS is financially sound and
growing, reporting 2003 net revenue of $91.1 million, up 37 percent
from 2002. Additional information is available at
http://www.ans-medical.com/ .
http://www.newscom.com/cgi-bin/prnh/20040901/DAW008 DATASOURCE:
Advanced Neuromodulation Systems, Inc. CONTACT: Megan Lozito,
+1-972-716-0500, ext. 14, or , for Advanced Neuromodulation
Systems, Inc. Web site: http://www.ans-medical.com/
Copyright
Advanced Neuromodulation (NASDAQ:ANSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Advanced Neuromodulation (NASDAQ:ANSI)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Advanced Neuromodulation Systems (MM) (NASDAQ): 0 recent articles
More Advanced Neuromodulation Systems (MM) News Articles